Research graph
References from Integrated immunogenomic analysis of single-cell and bulk profiling reveals novel tumor antigens and subtype-specific therapeutic agents in lung adenocarcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1371/journal.pmed.1002162
10.1371/journal.pmed.1002162 · External reference
Unraveling the expression patterns of immune checkpoints identifies new subtypes and emerging therapeutic indicators in lung adenocarcinoma
10.1155/2022/3583985 · 2022 · External reference
Integrated analysis of single-cell and bulk rna-sequencing identifies a signature based on b cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma
10.1007/s00262-022-03143-2 · 2022 · External reference
Rna-binding protein igf2bp1 associated with prognosis and immunotherapy response in lung adenocarcinoma
10.3389/fgene.2022.777399 · 2022 · External reference
Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mrna vaccine
10.1186/s12943-021-01452-1 · 2021 · External reference
10.1016/j.ymthe.2017.11.009
10.1016/j.ymthe.2017.11.009 · External reference
Mrna vaccine cv9103 and cv9104 for the treatment of prostate cancer
10.4161/hv.29553 · 2014 · External reference
10.1016/j.ymthe.2017.10.020
10.1016/j.ymthe.2017.10.020 · External reference
Phase ib study evaluating a self-adjuvanted mrna cancer vaccine (rnactive(r)) combined with local radiation as consolidation and maintenance treatment for patients with stage iv non-small cell lung cancer
10.1186/1471-2407-14-748 · 2014 · External reference
Self-adjuvanted mrna vaccination in advanced prostate cancer patients: a first-in-man phase i/iia study
10.1186/s40425-015-0068-y · 2015 · External reference
The cancer genome atlas (tcga): an immeasurable source of knowledge
2015 · External reference
10.1038/ng.2653
10.1038/ng.2653 · External reference
10.1038/sdata.2018.15
10.1038/sdata.2018.15 · External reference
Innatedb: systems biology of innate immunity and beyond--recent updates and continuing curation.
10.1093/nar/gks1147 · 2013 · External reference
10.21105/joss.01627
10.21105/joss.01627 · External reference
Gtse1 promotes prostate cancer cell proliferation via the sp1/foxm1 signaling pathway
10.1038/s41374-020-00510-4 · 2021 · External reference
10.1093/nar/gkv1507
10.1093/nar/gkv1507 · External reference
10.1016/j.cell.2018.02.052
10.1016/j.cell.2018.02.052 · External reference
10.1371/journal.pone.0010312
10.1371/journal.pone.0010312 · External reference
Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers
10.1126/scitranslmed.3005723 · 2013 · External reference
Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation
10.1158/1078-0432.ccr-12-1139 · 2013 · External reference
Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage ia patients
10.1097/jto.0000000000000042 · 2014 · External reference
10.1038/onc.2015.375
10.1038/onc.2015.375 · External reference
10.1093/bioinformatics/btm254
10.1093/bioinformatics/btm254 · External reference
10.1093/bioinformatics/bts034
10.1093/bioinformatics/bts034 · External reference
10.1038/nmeth.2810
10.1038/nmeth.2810 · External reference
Pinsplus: a tool for tumor subtype discovery in integrated genomic data
10.1093/bioinformatics/bty1049 · 2019 · External reference
10.1093/bioinformatics/btz058
10.1093/bioinformatics/btz058 · External reference
10.1016/j.cell.2014.06.049
10.1016/j.cell.2014.06.049 · External reference
10.1023/a:1023949509487
10.1023/a:1023949509487 · External reference
Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival
10.1038/s41467-018-06921-8 · 2018 · External reference
Mocluster: identifying joint patterns across multiple omics data sets
10.1021/acs.jproteome.5b00824 · 2016 · External reference
10.1371/journal.pone.0015543
10.1371/journal.pone.0015543 · External reference
Identification and validation of the immune subtypes of lung adenocarcinoma: implications for immunotherapy
10.3389/fcell.2020.00550 · 2020 · External reference
10.1007/s00432-023-05000-w
10.1007/s00432-023-05000-w · External reference
Identification of an immune classification and prognostic genes for lung adenocarcinoma based on immune cell signatures
10.3389/fmed.2022.855387 · 2022 · External reference
Molecular subtypes based on cnvs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
10.1016/j.neo.2021.05.006 · 2021 · External reference
10.1016/j.immuni.2018.03.023
10.1016/j.immuni.2018.03.023 · External reference
10.1007/978-1-4939-7493-1_12
10.1007/978-1-4939-7493-1_12 · External reference
10.1101/2020.12.03.400754
10.1101/2020.12.03.400754 · External reference
10.1007/s00262-017-2058-z
10.1007/s00262-017-2058-z · External reference
Gsva: gene set variation analysis for microarray and rna-seq data
10.1186/1471-2105-14-7 · 2013 · External reference
10.1038/ncomms3612
10.1038/ncomms3612 · External reference
10.1016/j.cell.2018.03.035
10.1016/j.cell.2018.03.035 · External reference
Integrated multi-omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer
10.1002/ctm2.655 · 2021 · External reference
10.1101/gr.239244.118
10.1101/gr.239244.118 · External reference
10.1186/s13059-016-0893-4
10.1186/s13059-016-0893-4 · External reference
Fraction genome altered (fga) to regulate both cell autonomous and non-cell autonomous functions in prostate cancer and its effect on prostate cancer aggressiveness
10.1200/jco.2020.38.6_suppl.347 · 2020 · External reference
10.1200/jco.2017.75.3384
10.1200/jco.2017.75.3384 · External reference
10.1016/j.cell.2017.09.007
10.1016/j.cell.2017.09.007 · External reference
Histone modifications and cancer
10.1101/cshperspect.a019521 · 2016 · External reference
10.1038/s41467-020-16164-1
10.1038/s41467-020-16164-1 · External reference
Seurat: visual analytics for the integrated analysis of microarray data
10.1186/1755-8794-3-21 · 2010 · External reference
Inference and analysis of cell-cell communication using cellchat
2021 · External reference
Limma: linear models for microarray data
2005 · External reference
10.1093/bioinformatics/btx346
10.1093/bioinformatics/btx346 · External reference
The cancer/testis antigen hormad1 mediates epithelial-mesenchymal transition to promote tumor growth and metastasis by activating the wnt/beta-catenin signaling pathway in lung cancer
10.1038/s41420-022-00946-1 · 2022 · External reference
10.1186/s12964-022-00875-7
10.1186/s12964-022-00875-7 · External reference
10.1016/j.cell.2016.06.017
10.1016/j.cell.2016.06.017 · External reference
10.1038/nchembio.1986
10.1038/nchembio.1986 · External reference
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling.
10.1038/s43018-019-0018-6 · 2020 · External reference
10.4168/aair.2015.7.1.14
10.4168/aair.2015.7.1.14 · External reference
Prrophetic: an r package for prediction of clinical chemotherapeutic response from tumor gene expression levels
10.1371/journal.pone.0107468 · 2014 · External reference
Movics: an r package for multi-omics integration and visualization in cancer subtyping
10.1093/bioinformatics/btaa1018 · 2020 · External reference
Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mrna vaccine development
10.1186/s12943-021-01342-6 · 2021 · External reference
Identification of tumor antigens and immune subtypes of glioblastoma for mrna vaccine development
10.3389/fimmu.2022.773264 · 2022 · External reference
10.1158/2159-8290.cd-20-0522
10.1158/2159-8290.cd-20-0522 · External reference
Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
10.1002/ctm2.601 · 2021 · External reference
The checkpoint response to replication stress
10.1016/j.dnarep.2009.04.014 · 2009 · External reference
10.1038/s41419-020-02858-3
10.1038/s41419-020-02858-3 · External reference
10.1038/s41388-020-01477-8
10.1038/s41388-020-01477-8 · External reference
10.1038/nrc3239
10.1038/nrc3239 · External reference
10.1002/1878-0261.12851
10.1002/1878-0261.12851 · External reference
Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through emap ii
10.1186/1756-9966-32-12 · 2013 · External reference
A phase ii clinical trial of sorafenib in androgen-independent prostate cancer
10.1158/1078-0432.ccr-07-1355 · 2008 · External reference
10.1158/1078-0432.ccr-15-1435
10.1158/1078-0432.ccr-15-1435 · External reference
Patients with myelodysplastic syndromes treated with azacitidine in clinical practice: the avida registry
10.3109/10428194.2014.935366 · 2015 · External reference
Inhibition of mir-155-5p exerts anti-fibrotic effects in silicotic mice by regulating meprin alpha
10.1016/j.omtn.2019.11.018 · 2020 · External reference
10.1084/jem.20090547
10.1084/jem.20090547 · External reference
10.1093/intimm/dxm127
10.1093/intimm/dxm127 · External reference
10.1016/j.jmb.2013.09.029
10.1016/j.jmb.2013.09.029 · External reference
10.1016/j.bbcan.2012.04.007
10.1016/j.bbcan.2012.04.007 · External reference
Driver and novel genes correlated with metastasis of non-small cell lung cancer: a comprehensive analysis
10.1016/j.prp.2021.153551 · 2021 · External reference
Meprins, membrane-bound and secreted astacin metalloproteinases
10.1016/j.mam.2008.08.002 · 2008 · External reference
Mep1a contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma
10.1002/hep.28397 · 2016 · External reference
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma
10.1016/j.ejca.2010.11.021 · 2011 · External reference
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses
2008 · External reference
Azacitidine improves the t-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia
10.1016/j.leukres.2015.06.007 · 2015 · External reference